Denali Therapeutics IPO Info

Company Name: Denali Therapeutics
Stock Symbol: DNLI
Exchange: NASDAQ
Status: Priced
IPO Date: 12/8/2017
IPO Price: 18.00 (18.89%)
Underwriters
Goldman Sachs & Co. LLC, Morgan Stanley and J.P. Morgan

Amount of Offering: N/A
Number of Shares Offered: 13.889 Mil
Shares Outstanding After Offering: N/A
Valuation: N/A
Company Description
Denali is a biopharmaceutical company developing a broad portfolio of therapeutic candidates for neurodegenerative diseases. Denali is based in South San Francisco.

News Headlines